Actively Recruiting
Male Supplements for Sperm Quality and Aging
Led by Kaohsiung Veterans General Hospital. · Updated on 2024-08-02
50
Participants Needed
1
Research Sites
92 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study investigates the effects of a new supplement on sperm quality in men with poor sperm quality. Fifty patients will receive the supplement for three months, followed by semen analysis and assessment of sperm aging and mitochondrial function. Changes in sexual function and aging symptoms will also be evaluated.
CONDITIONS
Official Title
Male Supplements for Sperm Quality and Aging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Poor sperm quality based on WHO criteria for human semen analysis
- Body mass index (BMI) between 18 and 30 kg/m2
You will not qualify if you...
- Azoospermia (no sperm in semen)
- Presence of varicocele
- Chromosome anomalies
- Any malignancy
- Use of hormone therapy or supplements within the last 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
Actively Recruiting
Research Team
L
Li-Te Lin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here